Skip to main content

RHUMBLINE ADVISERS

Position in PFE — Pfizer Inc

CIK 1115418 BOSTON, MA

Position in PFE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$207,319,240
-$41,904,378 QoQ
Shares Held
8,609,603
-3.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#63
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 59% Shared 0% None 41%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. PFE ranks #7 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PFE
Pfizer Inc
This page
8,609,603 $207,319,240

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $207,319,240 8,609,603
2026-03-31 $249,223,618 8,875,485
2025-12-31 $219,365,339 8,809,853
2025-09-30 $230,012,673 9,027,185
2025-06-30 $218,659,344 9,020,600
2025-03-31 $239,707,176 9,459,636
2024-12-31 $256,628,589 9,673,147
2024-09-30 $281,545,828 9,728,605
2024-06-30 $278,628,393 9,958,127
2024-03-31 $277,321,040 9,993,551
2023-12-31 $296,417,147 10,295,837
2023-09-30 $345,747,295 10,423,494
2023-06-30 $378,063,180 10,307,066
2023-03-31 $414,258,801 10,153,402
2022-12-31 $500,250,073 9,762,882
2022-09-30 $410,711,099 9,385,537
2022-06-30 $485,769,979 9,265,115
2022-03-31 $453,283,417 8,755,716
2021-12-31 $508,274,587 8,607,529
2021-09-30 $368,717,461 8,572,831
2021-06-30 $328,311,996 8,383,861
2021-03-31 $325,776,210 8,991,891
2020-12-31 $347,152,680 9,430,934
2020-09-30 $344,296,379 9,381,382
2020-06-30 $303,796,949 9,290,417
2020-03-31 $288,266,428 8,831,704